Watchful Waiting as a Strategy for Reducing Low-value Spinal Imaging

December 5, 2024 updated by: University of California, Davis
The investigators will learn from the study whether actors playing the roles of patients (standardized patients) can help primary care and urgent care clinicians develop skill in offering watchful waiting to patients with acute low back pain as a means of averting low-value spinal imaging. Using patient and physician feedback, this study will refine and evaluate -- in a controlled experiment -- a simulated standardized patient intervention to enhance primary care physician use of watchful waiting when patients request low-value spinal imaging. The long-term goal of this study is to discover communication strategies primary care physicians can use to avert costly, potentially harmful testing while maintaining the patient-doctor relationship.

Study Overview

Status

Completed

Conditions

Detailed Description

Overutilization is increasingly viewed within the framework of patient safety. In primary care, patients with acute low back pain frequently request diagnostic imaging, and primary and urgent care clinicians feel pressure to acquiesce to such requests to sustain patient trust and satisfaction. Spinal imaging in patients with acute low back pain poses risks from diagnostic evaluation of false-positive findings, patient labeling and anxiety, and unnecessary treatment (including spinal surgery) with potential downstream complications.

Watchful waiting advice has been found an effective strategy to reduce low-value treatment (e.g., pediatric ear infections), and some evidence suggests a watchful waiting approach would be acceptable to many patients requesting tests. Meanwhile, psychological theory suggests that physician messages could be tailored to magnify patient acceptance of a watchful waiting strategy.

The investigators will refine and evaluate a novel simulated intervention using standardized patients (SPs) -- or actors playing the roles of patients - to teach clinicians to endorse a watchful waiting approach when patients request low-value spinal imaging for low back pain. Specific aims are:

Aim 1: To use key informant interviews of front-line clinicians and focus groups with primary care patients to refine a theory-informed standardized patient-based intervention designed to teach practicing clinicians how to advise watchful waiting when patients request low-value spinal imaging for low back pain.

Aim 2: To test the effectiveness of standardized patient instructor (SPI)-delivered clinician training in the use of watchful waiting in a randomized clinical trial.

The investigators hypothesize that the intervention will: a) reduce rates of low-value spinal imaging among actual patients with acute back pain seen by clinicians post-intervention (adjusting for pre-trial rates); b) increase clinician advice to pursue watchful waiting during a followup visit with an unannounced SP; c) increase clinician self-reported use and efficacy of advising watchful waiting with actual low back pain patients; and d) have no adverse impact on actual patient trust and satisfaction with physicians; and e) reduce rates of neck imaging (among neck pain patients) and overall diagnostic testing (among all adult patients).

Aim 3: To assess whether the intervention effects generalize to other low-value imaging tests and diagnostic tests in general.

The investigators hypothesize that the SP intervention will: a) decrease rates of neck imaging among actual patients with neck pain seen by study clinicians during the follow-up period (adjusting for baseline rates); b) decrease rates of overall diagnostic tests among all adult patient seen by study clinicians during the follow-up period (adjusting for baseline rates); and c) increase PCP self-reported use and efficacy of advising watchful waiting for patients with neck pain, other musculoskeletal pain, and other non-musculoskeletal somatic complaints.

Study Type

Interventional

Enrollment (Actual)

67

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sacramento, California, United States, 95817
        • UC Davis Center for Healthcare Policy and Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria: Primary care and urgent care clinicians in the two health systems will be eligible if:

  1. they intend to practice either at least 50% full-time equivalent (FTE) adult primary or urgent care in one of the target clinics for the trial duration
  2. they have been in active full-time or 50% FTE practice within the health system for at least two years prior to enrollment (to enable collection of baseline testing rates).
  3. Nurse practitioners and physicians assistants will be eligible if they practice in the capacity of a primary care or urgent care clinicians and meet the other requirement above.

Exclusion Criteria:

  • None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Primary care and urgent care clinicians randomized to the intervention arm will receive two to three visits with a standardized patient instructor who will physicians how to facilitate patient acceptance of a watchful waiting strategy with regard to spinal imaging in the context of acute low back pain.
Clinicians randomized to the intervention group will receive 2-3 visits with a standardized patient instructor (SPI) scheduled during usual office hours over ~3 month period. For intervention physicians, SPIs will portray patients with acute back pain and will provide formative feedback to physicians and specific instruction in communication techniques to facilitate patient acceptance of a watchful waiting strategy with respect to spinal imaging. The specific communication techniques and sequence will be determined based on pre-trial literature review, patient focus groups, and interviews of primary care physicians who will not participate in the trial.
Placebo Comparator: Control
Primary care and urgent care clinicians randomized to the control arm will receive a single visit with a standardized patient who simulates a visit with patient with acute low back pain but will deliver no instruction on patient communication or other content.
Clinicians randomized to the control group will receive a single visit with a standardized patient instructor (SPI) scheduled during usual office hours. SPIs will portray a patients with acute back pain but will deliver no formative training or feedback to the primary care physicians randomized to the control arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adjusted rate of spinal imaging during 18-month follow-up
Time Frame: 18 months following date of first SPI visit
Rate of lumbar spinal x-ray, CT, or MRI during follow-up period, adjusted for imaging rate during 12 month pre-randomization period
18 months following date of first SPI visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adjusted rate of advanced spinal imaging during 18-month follow-up
Time Frame: 18 months following date of first SPI visit
Rate of lumbar CT or MRI during follow-up period, adjusted for imaging rate during 12 month pre-randomization period
18 months following date of first SPI visit
Adjusted rate of lumbar x-ray imaging during 18-month follow-up
Time Frame: 18 months following date of first SPI visit
Rate of lumbar x-ray during follow-up period, adjusted for imaging rate during 12 month pre-randomization period
18 months following date of first SPI visit
Use of watchful waiting communication techniques based on coded transcripts
Time Frame: 6 months post-intervention
Using transcripts of audio-recordings of a single post-intervention SP visit per randomized physician, investigators will identify physicians' use of communication techniques targeted by the intervention based on coding conducted by trained research assistants. Communication techniques will be identified based on a coding manual that will be developed by the investigators using transcripts of baseline standardized patient visits prior to instruction. The outcome will be a count of targeted communication techniques used during the follow-up visits. Investigators will report the relative rate of technique use adjusted for counts of techniques used during baseline standardized patient visits.
6 months post-intervention
Physician self-reported use of watchful waiting techniques in post-intervention questionnaires
Time Frame: 6 months post-intervention
Study physicians will complete an on-line survey 6 months after final SPI visits and will report the frequency of use of watchful waiting techniques on Likert scales created by the investigators for this project.
6 months post-intervention
Adjusted rate of neck imaging during 18-month follow-up
Time Frame: 18 months following date of first SPI visit
Rate of neck x-ray, CT, or MRI during follow-up period, adjusted for imaging rate during 12 month pre-randomization period
18 months following date of first SPI visit
Adjusted rate of diagnostic test ordering during 18-month follow-up
Time Frame: 18 months following date of first SPI visit
Rate of diagnostic test ordering (laboratory, imaging, cardiac, gastrointestinal and vascular tests) during 18 month follow-up period, adjusted for diagnostic test ordering rate during 12 month pre-randomization period
18 months following date of first SPI visit
Patient experience ratings during 18-month follow-up
Time Frame: 18 months following date of first SPI visit
Mean difference (vs. baseline period) in percent of patients rating clinicians either 9 or 10 on the Consumer Assessment of Healthcare Providers and Systems Overall Doctor Rating Scale
18 months following date of first SPI visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joshua J Fenton, MD, MPH, University of California, Davis

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2020

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

November 30, 2024

Study Registration Dates

First Submitted

January 16, 2020

First Submitted That Met QC Criteria

February 3, 2020

First Posted (Actual)

February 5, 2020

Study Record Updates

Last Update Posted (Estimated)

December 10, 2024

Last Update Submitted That Met QC Criteria

December 5, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1534721

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data would be shared with other researchers if their research protocols were institutional review board approved, and our team had sufficient time and resources to generate the individual participant data for secure data transfer.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Intervention

Subscribe